PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26326N0261Allosure in-home patient testing — Caredx, Inc

Caredx, Inc holds $10.5M across 27 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C26325D0021. Recompete timing centers on the Jan 14, 2027 PoP end — agencies typically plan 12–18 months ahead.

Network Contract Office 23 (36C263)

Awarding office

Caredx, Inc

Recipient

Jan 14, 2027

PoP end

$142K

Obligated

$142K

Potential

325413

NAICS

Q301

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Caredx, Inc — $90

Contract facts

Federal

Contract number36C26326N0261

Also listed as36C263-26-N-0261

Also listed as36C26325D0021-36C26326N0261

AgencyNetwork Contract Office 23 (36C263)

Awarding officeNetwork Contract Office 23 (36C263)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentCaredx, Inc

CAGE53C84

UEIY371A27ZEUM4

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSCQ301

Parent IDIQ / IDV36C26325D0021

Place of performanceIOWA CITY IA

Pricing typeFirm Fixed Price

Extent competedNot Competed

PoP startJan 15, 2026

PoP end (current)Jan 14, 2027

PoP end (w/ options)Jan 13, 2028

Obligated$142K

Current value$142K

Potential value$142K

ALLOSURE IN-HOME PATIENT TESTING is a federal award for Network Contract Office 23 (36C263) held by Caredx, Inc. Estimated value $142K ($142K obligated). Current period of performance ends Jan 14, 2027 (potential Jan 13, 2028). Place of performance: IOWA CITY IA.

Recompete timing

Public

● Expiring in 146 days

Current PoP ends Jan 14, 2027 (146 days remaining). Agencies typically plan 12–18 months ahead — at 4.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Caredx, Inc — $10.5M obligated across 27 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$10.5M · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

36C24925N0545

GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)

$492K

Sep 22, 2026

36C25221N0645

ALLOSURE KIDNEY TESTING

$486K

Sep 29, 2026

36C25226N0079

TRANSPLANT TESTING KITS

$1.6M

Jan 31, 2027

36C26122C0017

ALLOMAP AND ALLOSURE POST HEART TRANSPLANT REJECTION SURVEILLANCE TESTS SERVICES

$1.3M

Feb 28, 2027

36C25626N0370

LAB TESTS FOR POST TRANSPLANT CARE.

$771K

Mar 31, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26326N0261?

36C26326N0261 (Allosure in-home patient testing) is a Network Contract Office 23 (36C263) award with a potential value of $142K, currently held by Caredx, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C263-26-N-0261?

36C263-26-N-0261 is the dashed form of PIID 36C26326N0261 (Allosure in-home patient testing), held by Caredx, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26326N0261?

Network Contract Office 23 (36C263) awarded 36C26326N0261 to Caredx, Inc (potential $142K).

Who is the incumbent on 36C26326N0261?

Caredx, Inc is the incumbent with $10.5M across 27 related awards in SCOUT’s public footprint. The current period of performance ends Jan 14, 2027.

When does Caredx, Inc’s 36C26326N0261 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 14, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Nov 18, 2025